Parkside Financial Bank & Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268K | Buy |
4,272
+232
| +6% | +$18.6K | 0.02% | 383 |
|
|
2025
Q4 | $385K | Sell |
4,040
-283
| -7% | -$27.7K | 0.03% | 303 |
|
|
2025
Q3 | $422K | Sell |
4,323
-213
| -5% | -$22.1K | 0.03% | 281 |
|
|
2025
Q2 | $487K | Buy |
4,536
+1,142
| +34% | +$116K | 0.05% | 247 |
|
|
2025
Q1 | $342K | Buy |
3,394
+253
| +8% | +$25.5K | 0.04% | 283 |
|
|
2024
Q4 | $281K | Sell |
3,141
-492
| -14% | -$43.3K | 0.04% | 306 |
|
|
2024
Q3 | $304K | Buy |
3,633
+50
| +1% | +$3.94K | 0.04% | 280 |
|
|
2024
Q2 | $276K | Buy |
3,583
+45
| +1% | +$3.29K | 0.04% | 284 |
|
|
2024
Q1 | $242K | Buy |
3,538
+285
| +9% | +$18.3K | 0.04% | 312 |
|
|
2023
Q4 | $188K | Sell |
3,253
-229
| -7% | -$12.2K | 0.03% | 323 |
|
|
2023
Q3 | $184K | Buy |
3,482
+627
| +22% | +$32.9K | 0.04% | 275 |
|
|
2023
Q2 | $154K | Sell |
2,855
-22
| -0.8% | -$1.15K | 0.04% | 302 |
|
|
2023
Q1 | $144K | Buy |
2,877
+121
| +4% | +$5.7K | 0.04% | 299 |
|
|
2022
Q4 | $128K | Buy |
2,756
+1,142
| +71% | +$49.5K | 0.04% | 318 |
|
|
2022
Q3 | $62K | Sell |
1,614
-115
| -7% | -$4.61K | 0.02% | 457 |
|
|
2022
Q2 | $64K | Sell |
1,729
-64
| -4% | -$2.6K | 0.02% | 449 |
|
|
2022
Q1 | $79K | Buy |
1,793
+306
| +21% | +$13.3K | 0.02% | 411 |
|
|
2021
Q4 | $63K | Sell |
1,487
-47
| -3% | -$1.98K | 0.02% | 464 |
|
|
2021
Q3 | $67K | Buy |
1,534
+47
| +3% | +$2.08K | 0.02% | 415 |
|
|
2021
Q2 | $64K | Buy |
1,487
+111
| +8% | +$4.67K | 0.02% | 434 |
|
|
2021
Q1 | $53K | Buy |
1,376
+100
| +8% | +$3.79K | 0.02% | 462 |
|
|
2020
Q4 | $46K | Sell |
1,276
-669
| -34% | -$24.1K | 0.01% | 481 |
|
|
2020
Q3 | $74K | Sell |
1,945
-52
| -3% | -$2K | 0.03% | 348 |
|
|
2020
Q2 | $70K | Buy |
1,997
+54
| +3% | +$1.95K | 0.02% | 362 |
|
|
2020
Q1 | $63K | Sell |
1,943
-175
| -8% | -$6.84K | 0.02% | 337 |
|
|
2019
Q4 | $96K | Sell |
2,118
-33
| -2% | -$1.38K | 0.03% | 305 |
|
|
2019
Q3 | $88K | Sell |
2,151
-12
| -0.6% | -$508 | 0.03% | 298 |
|
|
2019
Q2 | $93K | Sell |
2,163
-1
| -0% | -$38 | 0.03% | 286 |
|
|
2019
Q1 | $83K | Sell |
2,164
-721
| -25% | -$27.5K | 0.03% | 283 |
|
|
2018
Q4 | $102K | Buy |
2,885
+1,721
| +148% | +$62.4K | 0.04% | 247 |
|
|
2018
Q3 | $45K | Buy |
1,164
+117
| +11% | +$4.09K | 0.02% | 392 |
|
|
2018
Q2 | $34K | Buy |
1,047
+112
| +12% | +$3.38K | 0.01% | 442 |
|
|
2018
Q1 | $25K | Buy |
935
+218
| +30% | +$5.92K | 0.01% | 503 |
|
|
2017
Q4 | $18K | Sell |
717
-261
| -27% | -$7.2K | 0.01% | 596 |
|
|
2017
Q3 | $29K | Buy |
978
+154
| +19% | +$4.25K | 0.01% | 448 |
|
|
2017
Q2 | $23K | Buy |
824
+210
| +34% | +$5.57K | 0.01% | 502 |
|
|
2017
Q1 | $15K | Buy |
614
+59
| +11% | +$1.44K | 0.01% | 596 |
|
|
2016
Q4 | $12K | Sell |
555
-166
| -23% | -$3.62K | 0.01% | 650 |
|
|
2016
Q3 | $17K | Buy |
721
+41
| +6% | +$978 | 0.01% | 601 |
|
|
2016
Q2 | $16K | Buy |
680
+30
| +5% | +$649 | 0.01% | 588 |
|
|
2016
Q1 | $12K | Buy |
650
+514
| +378% | +$9.03K | 0.01% | 618 |
|
|
2015
Q4 | $3K | Buy |
136
+31
| +30% | +$555 | ﹤0.01% | 832 |
|
|
2015
Q3 | $2K | Buy |
+105
| New | +$1.79K | ﹤0.01% | 902 |
|
Other funds holding BSX
VCM
VPM
Parkside Financial Bank & Trust's BSX Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its Boston Scientific (BSX) stake by 5.7% in Q1 2026, buying an estimated $18.6K and bringing the position to 4,272 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #383.
Parkside Financial Bank & Trust first reported a position in BSX in Q3 2015 and has held it in 43 quarters since. The position peaked at $487K in Q2 2025. 1,668 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Parkside Financial Bank & Trust held 4,272 shares of Boston Scientific worth $268K as of Q1 2026.
- Parkside Financial Bank & Trust bought 232 Boston Scientific shares in Q1 2026, an estimated $18.6K.
- Boston Scientific made up 0.02% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #383 holding.
- Parkside Financial Bank & Trust first reported a position in Boston Scientific in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Boston Scientific position peaked at $487K in Q2 2025.
- 1,668 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.